APA (7th ed.) Citation

SK, M., SK, S., B, A., A, D., K, B., M, K., . . . I, M. S. (2024). Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma. Journal for immunotherapy of cancer, 12(5), . https://doi.org/10.1136/jitc-2024-008817

Chicago Style (17th ed.) Citation

SK, Mørk, et al. "Dose Escalation Study of a Personalized Peptide-based Neoantigen Vaccine (EVX-01) in Patients with Metastatic Melanoma." Journal for Immunotherapy of Cancer 12, no. 5 (2024). https://doi.org/10.1136/jitc-2024-008817.

MLA (9th ed.) Citation

SK, Mørk, et al. "Dose Escalation Study of a Personalized Peptide-based Neoantigen Vaccine (EVX-01) in Patients with Metastatic Melanoma." Journal for Immunotherapy of Cancer, vol. 12, no. 5, 2024, https://doi.org/10.1136/jitc-2024-008817.